Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States.
OBJECTIVE
This study assessed overdose and naloxone administration knowledge among current or former opioid abusers trained and untrained in overdose-response in the United States.


METHODS
Ten individuals, divided equally between those trained or not trained in overdose recognition and response, were recruited from each of six sites (n = 62).


METHODS
US-based overdose training and naloxone distribution programs in Baltimore, San Francisco, Chicago, New York and New Mexico.


METHODS
Participants completed a brief questionnaire on overdose knowledge that included the task of rating 16 putative overdose scenarios for: (i) whether an overdose was occurring and (ii) if naloxone was indicated. Bivariate and multivariable analyses compared results for those trained to untrained. Responses were also compared to those of 11 medical experts using weighted and unweighted kappa statistics.


RESULTS
Respondents were primarily male (72.6%); 45.8% had experienced an overdose and 72% had ever witnessed an overdose. Trained participants recognized more opioid overdose scenarios accurately (t(60) = 3.76, P < 0.001) and instances where naloxone was indicated (t(59) = 2.2, P < 0.05) than did untrained participants. Receipt of training and higher perceived competency in recognizing signs of an opioid overdose were associated independently with higher overdose recognition scores. Trained respondents were as skilled as medical experts in recognizing opioid overdose situations (weighted kappa = 0.85) and when naloxone was indicated (kappa = 1.0).


CONCLUSIONS
Results suggest that naloxone training programs in the United States improve participants' ability to recognize and respond to opioid overdoses in the community. Drug users with overdose training and confidence in their abilities to respond may effectively prevent overdose mortality.
Green
Traci C
TC
Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06520-8034, USA. traci.c.green@yale.edu
Heimer
Robert
R
Grau
Lauretta E
LE
D002983:Clinical Competence; D003937:Diagnosis, Differential; D062787:Drug Overdose / Q000175:diagnosis / Q000188:drug therapy; D004638:Emergency Treatment / Q000379:methods* / Q000592:standards; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008297:Male; D015999:Multivariate Analysis; D009270:Naloxone / Q000600:supply & distribution / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000600:supply & distribution / Q000627:therapeutic use*; D009293:Opioid-Related Disorders / Q000175:diagnosis / Q000188:drug therapy*; D015397:Program Evaluation
D009292:Narcotic Antagonists; D009270:Naloxone